Correlation Between Quoin Pharmaceuticals and Acrivon Therapeutics,

Can any of the company-specific risk be diversified away by investing in both Quoin Pharmaceuticals and Acrivon Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quoin Pharmaceuticals and Acrivon Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Quoin Pharmaceuticals Ltd and Acrivon Therapeutics, Common, you can compare the effects of market volatilities on Quoin Pharmaceuticals and Acrivon Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quoin Pharmaceuticals with a short position of Acrivon Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quoin Pharmaceuticals and Acrivon Therapeutics,.

Diversification Opportunities for Quoin Pharmaceuticals and Acrivon Therapeutics,

0.42

Correlation Coefficient

Quoin Pharmaceuticals  Acrivon Therapeutics,

Very weak diversification

The 3 months correlation between Quoin and Acrivon is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Quoin Pharmaceuticals Ltd and Acrivon Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acrivon Therapeutics, and Quoin Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quoin Pharmaceuticals Ltd are associated (or correlated) with Acrivon Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acrivon Therapeutics, has no effect on the direction of Quoin Pharmaceuticals i.e., Quoin Pharmaceuticals and Acrivon Therapeutics, go up and down completely randomly.

Pair Corralation between Quoin Pharmaceuticals and Acrivon Therapeutics,

Given the investment horizon of 90 days Quoin Pharmaceuticals Ltd is expected to generate 1.96 times more return on investment than Acrivon Therapeutics,. However, Quoin Pharmaceuticals is 1.96 times more volatile than Acrivon Therapeutics, Common. It trades about 0.03 of its potential returns per unit of risk. Acrivon Therapeutics, Common is currently generating about 0.03 per unit of risk. If you would invest  62.00  in Quoin Pharmaceuticals Ltd on September 22, 2024 and sell it today you would lose (5.00) from holding Quoin Pharmaceuticals Ltd or give up 8.06% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Quoin Pharmaceuticals Ltd  vs.  Acrivon Therapeutics, Common

Quoin Pharmaceuticals

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Quoin Pharmaceuticals Ltd are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Quoin Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Acrivon Therapeutics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Acrivon Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Acrivon Therapeutics, is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Quoin Pharmaceuticals and Acrivon Therapeutics,

The main advantage of trading using opposite Quoin Pharmaceuticals and Acrivon Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quoin Pharmaceuticals position performs unexpectedly, Acrivon Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acrivon Therapeutics, will offset losses from the drop in Acrivon Therapeutics,'s long position.

The idea behind Quoin Pharmaceuticals Ltd and Acrivon Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.